AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23590727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21466925 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent training plus incentives (PTI)
Number of subjects: 47
Study 21466925 — intervention group
Group type: COMPARATOR
Intervention: Parent training without incentives (PT)
Number of subjects: 47
Study 18619686 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP group
Number of subjects: 99
Study 18619686 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99
Study 17362251 — intervention group
Group type: EXPERIMENTAL
Intervention: House dust mite and grass allergen challenge
Number of subjects: 37
Study 17362251 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheal size
Number of subjects: 37
Study 17362251 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen-specific immunoglobulin E (IgE)
Number of subjects: 37
Study 17362251 — intervention group
Group type: EXPERIMENTAL
Intervention: Total IgE
Number of subjects: 37
Study 17362251 — intervention group
Group type: EXPERIMENTAL
Intervention: Current wheeze
Number of subjects: 37
Study 17362251 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent eczema
Number of subjects: 37
Study 14769081 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% North African (or 30% Asian) faces
Number of subjects: 0
Study 14769081 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% North African (or 70% Asian) faces
Number of subjects: 0
Study 14769081 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely ambiguous (50%) faces
Number of subjects: 0
Study 14769081 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-race continua
Number of subjects: 0
Study 14769081 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of confidence
Number of subjects: 0
Study 12577374 — intervention group
Group type: EXPERIMENTAL
Intervention: Puerarin
Number of subjects: 59
Study 12577374 — intervention group
Group type: COMPARATOR
Intervention: Ticlid (Control)
Number of subjects: 59
Study 9502344 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (10 mg)
Number of subjects: 14
Study 9502344 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 7914736 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol combined with epidural block with bupivacaine
Number of subjects: 20
Study 7914736 — intervention group
Group type: COMPARATOR
Intervention: Propofol combined with alfentanil infusions
Number of subjects: 20
Study 3260967 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 20
Study 3260967 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 20
Study 3260967 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 20
Study 3260967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31971861 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut microbiome (GM) biomarkers identified from CRC patients
Number of subjects: 107
Study 31971861 — intervention group
Group type: EXPERIMENTAL
Intervention: Classifier based on identified biomarkers
Number of subjects: 107
Study 31971861 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative PCR for measuring biomarkers
Number of subjects: 107
Study 31272926 — intervention group
Group type: EXPERIMENTAL
Intervention: SNr stimulation
Number of subjects: 14
Study 31272926 — intervention group
Group type: EXPERIMENTAL
Intervention: STN stimulation
Number of subjects: 14
Study 31272926 — intervention group
Group type: COMPARATOR
Intervention: Off stimulation
Number of subjects: 14
Study 28241699 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginaton in addition to conventional treatment
Number of subjects: 116
Study 28241699 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 116
Study 26044447 — intervention group
Group type: EXPERIMENTAL
Intervention: Dia-Fit (web-based cognitive behaviour therapy)
Number of subjects: 120
Study 26044447 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group (control)
Number of subjects: 120
Study 23859675 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 323
Study 23859675 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 323
Study 21921152 — intervention group
Group type: EXPERIMENTAL
Intervention: Less Intensive (LI) belatacept regimen
Number of subjects: 336
Study 21921152 — intervention group
Group type: EXPERIMENTAL
Intervention: More Intensive (MI) belatacept regimen
Number of subjects: 336
Study 21921152 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 336
Study 21921152 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept (MI and LI)
Number of subjects: 336
Study 19689077 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-micronutrient supplement
Number of subjects: 275
Study 19689077 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 19689077 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 275
Study 17079638 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetaminophen 30 mg x kg(‐1)
Number of subjects: 124
Study 17079638 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2% lidocaine
Number of subjects: 124
Study 15646220 — intervention group
Group type: EXPERIMENTAL
Intervention: 5N HCl followed by 5%NaOCl
Number of subjects: 2
Study 15646220 — intervention group
Group type: EXPERIMENTAL
Intervention: 5%NaOCl
Number of subjects: 2
Study 15646220 — intervention group
Group type: EXPERIMENTAL
Intervention: 5%NaOCl and sonication
Number of subjects: 2
Study 15646220 — intervention group
Group type: EXPERIMENTAL
Intervention: 5%NaOCl followed by 5N HCl
Number of subjects: 2
Study 15646220 — intervention group
Group type: COMPARATOR
Intervention: Polished specimens
Number of subjects: 2
Study 11709248 — intervention group
Group type: EXPERIMENTAL
Intervention: Healon (sodium hyaluronate 1%)
Number of subjects: 50
Study 11709248 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscoat (sodium hyaluronate 3%-chondroitin sulfate 4%)
Number of subjects: 50
Study 11709248 — intervention group
Group type: COMPARATOR
Intervention: Both Healon and Viscoat
Number of subjects: 50
Study 9541149 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine treatment
Number of subjects: 20
Study 9541149 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study 8017642 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6% isoflurane in 66% nitrous oxide (group 2)
Number of subjects: 46
Study 8017642 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2% isoflurane in 66% nitrous oxide (group 4)
Number of subjects: 46
Study 8017642 — intervention group
Group type: COMPARATOR
Intervention: 0.6% isoflurane in 66% nitrous oxide (group 1)
Number of subjects: 46
Study 8017642 — intervention group
Group type: COMPARATOR
Intervention: 1.2% isoflurane in 66% nitrous oxide (group 3)
Number of subjects: 46
Study 2601309 — intervention group
Group type: EXPERIMENTAL
Intervention: Language-enriched day care program with parent education component
Number of subjects: 0
Study 2601309 — intervention group
Group type: COMPARATOR
Intervention: Parent education program without language-enriched day care
Number of subjects: 0
Study 2601309 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 5558187 — intervention group
Group type: EXPERIMENTAL
Intervention: Home care by the family doctor
Number of subjects: 1203
Study 5558187 — intervention group
Group type: COMPARATOR
Intervention: Hospital treatment initially in an intensive care unit
Number of subjects: 1203
Study 30980679 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing plus psychotherapy
Number of subjects: 60
Study 30980679 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy alone
Number of subjects: 60
Study 28595611 — intervention group
Group type: EXPERIMENTAL
Intervention: traditional clinic‐based CI therapy
Number of subjects: 224
Study 28595611 — intervention group
Group type: EXPERIMENTAL
Intervention: therapist‐as‐consultant video game CI therapy
Number of subjects: 224
Study 28595611 — intervention group
Group type: EXPERIMENTAL
Intervention: therapist‐as‐consultant video game CI therapy with additional therapist contact via telerehabilitation/video consultation
Number of subjects: 224
Study 28595611 — intervention group
Group type: COMPARATOR
Intervention: standard upper extremity rehabilitation
Number of subjects: 224
Study 27140799 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 100-mg doses of migalastat HCl capsule
Number of subjects: 35
Study 27140799 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 100-mg doses of migalastat HCl capsules with a high-fat meal
Number of subjects: 35
Study 27140799 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 150-mg doses of migalastat HCl capsules with a high-fat or light meal
Number of subjects: 35
Study 27140799 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-g glucose drink co-administered with migalastat HCl
Number of subjects: 35
Study 23520339 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention (telehealth equipment and monitoring services for 12 months)
Number of subjects: 3230
Study 23520339 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard health and social care)
Number of subjects: 3230
Study 21535185 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey
Number of subjects: 24
Study 21535185 — intervention group
Group type: EXPERIMENTAL
Intervention: CasPost
Number of subjects: 24
Study 21535185 — intervention group
Group type: EXPERIMENTAL
Intervention: CasPre
Number of subjects: 24
Study 21535185 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 18931097 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-management program
Number of subjects: 0
Study 16769001 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (4/0.5/8 h/i.v.)
Number of subjects: 183
Study 16769001 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole (500 mg/i.v./8 h) + Gentamicin (5 mg/kg/i.v./24 h)
Number of subjects: 183
Study 15577832 — intervention group
Group type: EXPERIMENTAL
Intervention: Cat hair and dander extract containing 0.6 mug of Fel d 1
Number of subjects: 28
Study 15577832 — intervention group
Group type: EXPERIMENTAL
Intervention: Cat hair and dander extract containing 3 mug of Fel d 1
Number of subjects: 28
Study 15577832 — intervention group
Group type: EXPERIMENTAL
Intervention: Cat hair and dander extract containing 15 mug of Fel d 1
Number of subjects: 28
Study 15577832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 15330272 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol esters (1.6g daily)
Number of subjects: 0
Study 15330272 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol esters (1.6g daily)
Number of subjects: 0
Study 15330272 — intervention group
Group type: COMPARATOR
Intervention: Plant stanol esters (2.6g daily)
Number of subjects: 0
Study 11121918 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic porcine secretin 0.2 microgram/kg
Number of subjects: 12
Study 11121918 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic porcine secretin 0.4 microgram/kg
Number of subjects: 12
Study 11121918 — intervention group
Group type: COMPARATOR
Intervention: Biologically derived porcine secretin 1 CU/kg
Number of subjects: 12
Study 8883191 — intervention group
Group type: EXPERIMENTAL
Intervention: Original Ashworth scale
Number of subjects: 30
Study 8883191 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Ashworth scale
Number of subjects: 30
Study 1304205 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-stitch (double running) suture closure
Number of subjects: 200
Study 1304205 — intervention group
Group type: COMPARATOR
Intervention: One-stitch technique
Number of subjects: 200
Study 1304205 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (4 weeks post-surgery)
Number of subjects: 200
Study 4028281 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacampicillin (16 g/die)
Number of subjects: 16
Study 4028281 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (2 g/die)
Number of subjects: 16
Study 3280741 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU and FA (folinic acid), 200 mg/m2/d for five consecutive days along with 5‐FU, 370 mg/m2/d for five days
Number of subjects: 130
Study 3280741 — intervention group
Group type: COMPARATOR
Intervention: 5‐FU alone
Number of subjects: 130
Study 31046810 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 days of antibiotic treatment
Number of subjects: 284
Study 31046810 — intervention group
Group type: COMPARATOR
Intervention: 14 days of antibiotic treatment
Number of subjects: 284
Study 28389609 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-initiated protocols for management of fever, hyperglycemia, and swallowing dysfunction
Number of subjects: 1076
Study 28389609 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1076
Study 25463962 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol dose condition (BAC .05 or .08)
Number of subjects: 44
Study 25463962 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 44
Study 23850630 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT) program
Number of subjects: 67
Study 21726496 — intervention group
Group type: EXPERIMENTAL
Intervention: oral ROF 500 μg q.d. on Days 6 - 10 in addition to oral THEO 375 mg b.i.d. on Days 1 - 10
Number of subjects: 24
Study 21726496 — intervention group
Group type: COMPARATOR
Intervention: oral ROF 500 μg q.d. on Days 1 - 5
Number of subjects: 24
Study 21726496 — intervention group
Group type: EXPERIMENTAL
Intervention: oral THEO 375 mg b.i.d. on Days 1 - 10
Number of subjects: 24
Study 19417675 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope
Number of subjects: 60
Study 19417675 — intervention group
Group type: EXPERIMENTAL
Intervention: Trachlight
Number of subjects: 60
Study 19417675 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 60
Study 17098656 — intervention group
Group type: COMPARATOR
Intervention: SC group (S): 10 mL of 0.25% bupivacaine and 10 mL of 0.9% saline
Number of subjects: 60
Study 17098656 — intervention group
Group type: EXPERIMENTAL
Intervention: C group: 10 mL of 0.25% bupivacaine (SF and SC)
Number of subjects: 60
Study 16305006 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching with peroxide and light (exact dosage and duration not specified)
Number of subjects: 43
Study 16305006 — intervention group
Group type: COMPARATOR
Intervention: Single-site measurement procedure
Number of subjects: 43
Study 16305006 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-site measurement procedure
Number of subjects: 43
Study 16305006 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth whitening procedures
Number of subjects: 43
Study 11575895 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol, 50 microg x 2 day(-1)
Number of subjects: 67
Study 11575895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 11575895 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 67
Study 11575895 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting bronchodilators (LABD)
Number of subjects: 67
Study 9772038 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxiglumide (10 mg/kg/h)
Number of subjects: 8
Study 9772038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7511552 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton irradiation as monotherapy (15 lesions)
Number of subjects: 24
Study 7511552 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton irradiation as combination therapy with Lipiodol-targeted chemotherapy (17 lesions)
Number of subjects: 24
Study 3403863 — intervention group
Group type: EXPERIMENTAL
Intervention: BN52063 (120 mg)
Number of subjects: 10
Study 3403863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31512395 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training (I-TRA)
Number of subjects: 35
Study 31512395 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous training (C-TRA)
Number of subjects: 35
Study 31512395 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 28124397 — intervention group
Group type: EXPERIMENTAL
Intervention: Nidotherapy
Number of subjects: 200
Study 28124397 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care Programme Approach (ECPA)
Number of subjects: 200
Study 25198942 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg once daily (Group A)
Number of subjects: 136
Study 25198942 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg once daily (Group B)
Number of subjects: 136
Study 23594140 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloral hydrate (CH) 50 mg/kg
Number of subjects: 282
Study 23594140 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyzine HCL (HH) 1 mg/kg
Number of subjects: 282
Study 21288233 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol 2,000 IU daily for 6 months
Number of subjects: 34
Study 21288233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 19200116 — intervention group
Group type: EXPERIMENTAL
Intervention: High-oleic genotypes (4896-11-C, 9399-10)
Number of subjects: 16
Study 19200116 — intervention group
Group type: COMPARATOR
Intervention: Normal peanuts
Number of subjects: 16
Study 16784345 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of affirmative action procedures
Number of subjects: 0
Study 16784345 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus on losses for the White in-group
Number of subjects: 0
Study 16784345 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus on gains for the Black out-group or no effect on Whites
Number of subjects: 0
Study 16784345 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived fairness
Number of subjects: 0
Study 15218439 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical metronidazole gel
Number of subjects: 0
Study 15218439 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15218439 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 11722961 — intervention group
Group type: EXPERIMENTAL
Intervention: Microencapsulated ferrous fumarate (80 mg elemental Fe) plus ascorbic acid (sprinkles group)
Number of subjects: 557
Study 11722961 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate drops (40 mg elemental Fe, administered 3 times/d for 2 months) (control group)
Number of subjects: 557
Study 11722961 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (sprinkles and drops)
Number of subjects: 557
Study 9465948 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar with iotrolan (11.2 mg iodine/ml)/guar (4 g/l) suspension
Number of subjects: 20
Study 9465948 — intervention group
Group type: COMPARATOR
Intervention: Aqueous solutions of pure iotrolan (11.2 mg iodine/ml)
Number of subjects: 20
Study 9465948 — intervention group
Group type: COMPARATOR
Intervention: Meglumine ioxithalamate (12 mg iodine/ml)
Number of subjects: 20
Study 9465948 — intervention group
Group type: COMPARATOR
Intervention: Pure iotrolan
Number of subjects: 20
Study 8192515 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (20 mg/kg/day) + Cimetidine (10 mg/kg/day)
Number of subjects: 19
Study 8192515 — intervention group
Group type: COMPARATOR
Intervention: Albendazole (20 mg/kg/day)
Number of subjects: 19
Study 3669497 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine HCl, 500 mg/kg
Number of subjects: 14
Study 3669497 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine HCl, 200 mg/kg
Number of subjects: 14
Study 3669497 — intervention group
Group type: COMPARATOR
Intervention: D-glucose infusion
Number of subjects: 14
Study 3669497 — intervention group
Group type: COMPARATOR
Intervention: Ammonium chloride with sodium chloride
Number of subjects: 14
Study 30833349 — intervention group
Group type: EXPERIMENTAL
Intervention: mixed online hemodiafiltration (mOL-HDF)
Number of subjects: 30
Study 30833349 — intervention group
Group type: COMPARATOR
Intervention: bicarbonate hemodialysis (BHD)
Number of subjects: 30
Study 28399098 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate variability biofeedback (HRV BF) session to enhance vagal influences on the heart rhythm.
Number of subjects: 150
Study 28399098 — intervention group
Group type: COMPARATOR
Intervention: Relaxed resting state (Control group).
Number of subjects: 150
Study 26109581 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral infusion of maltodextrins with protein powder (0.14 g proteins · kg⁻¹ · h⁻¹)
Number of subjects: 6
Study 26109581 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrins alone (0.25 g · kg⁻¹ · h⁻¹)
Number of subjects: 6
Study 24267861 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 328
Study 24267861 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention + pop-up reminder
Number of subjects: 328
Study 24267861 — intervention group
Group type: EXPERIMENTAL
Intervention: Pop-up reminder
Number of subjects: 328
Study 24267861 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper RTI, sinusitis, and otitis
Number of subjects: 328
Study 21279454 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART intervention (single 90 min one-on-one training)
Number of subjects: 40
Study 21279454 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 40
Study 19643435 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographically directed duration of indomethacin treatment (ECHO); 0.1 mg/kg
Number of subjects: 74
Study 19643435 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment; 0.1 mg/kg indomethacin, 2 more doses irrespective of echocardiographic findings
Number of subjects: 74
Study 17906164 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal domain tasks requiring supervision and coordination
Number of subjects: 0
Study 17906164 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial tasks
Number of subjects: 0
Study 17906164 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cognitive control processes
Number of subjects: 0
Study 15086643 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 98